Atlas Trials

Minimal Residual Disease as a Possible Predictive Factor for Relapse in Patients With AL Amyloidosis

Clinical trial NCT02555969 · COMPLETED

Trial details

NCT number
NCT02555969
Sponsor
Tufts Medical Center
Status
COMPLETED
Study type
OBSERVATIONAL
AmyloidosisPrimary Amyloidosis
Start date
2015-08-01
Primary completion
2020-08-01
Enrollment
56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.